News Conference News ESC 2025 ALONE-AF: Less Bleeding When OAC Stopped After Successful Ablation Todd Neale September 08, 2025
News Conference News ESOC 2025 High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants Todd Neale May 29, 2025
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
News Conference News ESC 2024 Asundexian for AF? More Details on the Sinking of OCEANIC-AF Shelley Wood September 02, 2024
News Conference News NY Valves 2024 Leaks After LAAO Do Matter, Experts Agree Todd Neale June 10, 2024
News Conference News ISC 2024 Speedier Anticoagulation Reversal Tied to Better ICH Outcomes Todd Neale February 15, 2024
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Conference News EACTS 2023 Combined Surgical and Catheter Ablation Best for Persistent AF Michael O'Riordan October 12, 2023
News Conference News ISC 2023 Does All AF After Stroke Warrant Anticoagulation? Experts Debate Todd Neale February 17, 2023
News Conference News EHRA 2021 STROKESTOP: Small Clinical Benefit Seen With Systematic AF Screening Todd Neale April 26, 2021
News Conference News A-fib Screening Yields Promising Results, But Uncertainty Remains: mSToPS and VITAL-AF Todd Neale November 19, 2020
News Conference News ISC 2020 Optimal Time to Start Anticoagulation After Stroke Remains Unclear Todd Neale February 27, 2020
News Conference News ESC 2019 Increasing Oral Anticoagulation Use Tied to Less Ischemic Stroke in A-fib Patients in Italy Todd Neale August 31, 2019
News Conference News ESC Heart Failure 2019 Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis Shelley Wood May 26, 2019
News Conference News EHRA 2019 Survey Says . . . Patients Like NOACs Better Than Warfarin Todd Neale March 17, 2019
News Conference News AHA 2018 Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF Todd Neale November 11, 2018
News Conference News ISC 2018 Experts Debate: Is It ‘Nuts’ to Restart Anticoagulation After Lobar ICH? Todd Neale January 30, 2018
News Conference News ISC 2017 NOAC-Related Intracranial Hemorrhages May Not Be as Bad as Those Stemming From Warfarin Todd Neale March 01, 2017
News Conference News ISC 2017 Restarting Oral Anticoagulation After Intracerebral Hemorrhage Tied to Better Outcomes Todd Neale February 27, 2017